NOS2 and cancer: Conversely, the prevalence of macrophages with M1-like phenotypes expressing IL-12, Tumor Necrosis Factor alpha (TNF-alpha), and Nitric Oxide Synthase 2 (NOS2) has been reported to correlate with favorable clinical outcomes in many human cancers [21,22,23].